Sulforaphane improves cognitive function administered following traumatic brain injury.

Area of Science:

• Neuroscience
• Pharmacology
• Biochemistry

Background:

• Traumatic brain injury (TBI) can lead to significant cognitive deficits.
• Sulforaphane, found in cruciferous vegetables, exhibits cytoprotective properties in brain injury models.
• Previous research indicates sulforaphane reduces blood-brain barrier permeability and cerebral edema post-TBI via Nrf2-driven gene induction.

Purpose of the Study:

• To investigate the efficacy of sulforaphane in ameliorating cognitive impairments following TBI.
• To determine if sulforaphane administration can improve performance in hippocampal- and prefrontal cortex-dependent tasks post-injury.

Main Methods:

• Rats were subjected to cortical impact injury to model TBI.
• Sulforaphane was administered at different time points (1h and 6h) post-injury.
• Cognitive function was assessed using the Morris water maze and delayed match-to-place tasks.

Main Results:

• Sulforaphane treatment initiated 1h post-TBI significantly improved performance in the Morris water maze, indicated by reduced learning latencies and better platform localization.
• Sulforaphane administration also ameliorated working memory deficits in the delayed match-to-place task.
• No cognitive benefits were observed when sulforaphane treatment was initiated 6h post-injury.

Conclusions:

• Early administration of sulforaphane following TBI enhances cognitive recovery in rats.
• These findings suggest sulforaphane's potential as a therapeutic agent for mitigating cognitive deficits associated with TBI.
• The study extends the known protective effects of sulforaphane to include cognitive enhancement post-brain injury.